Moderate- to high-quality evidence from an umbrella review on non-cardiometabolic outcomes reinforced links between GLP-1 therapies and risks of nausea, vomiting, and diarrhea. High-quality evidence ...

Severe ankle pain drove Jelon Smart to start taking a weight loss injection a year and a half ago. Smart was 285 pounds and worked as a caterer in Savannah, Georgia. After she’d been standing on her ...

GLP-1 medications showed a range of potential benefits and safety concerns in an umbrella review of non-cardiometabolic outcomes, though the data quality for many remained limited. Across 60 ...

Glucagon-like peptide-1 (GLP-1) receptor agonists are incretin analogues that promote glucose-mediated insulin release and are used to treat type 2 diabetes mellitus and obesity. GLP-1 receptor ...

GLP-1 medications can alter bowel movements, with constipation and diarrhea being the most common side effects. These drugs slow digestion to help control appetite, which can lead to changes in stool ...

The online health platform Hers has launched a new weight loss membership for GLP-1 treatments. The membership starts at $39 for the first month and then costs $149 per month. Hers offers various ...

The US Food and Drug Administration on Wednesday approved the second GLP-1 pill for weight loss, adding another option to a rapidly growing arsenal of obesity therapies. The orforglipron pill, called ...

While Lilly’s position in the obesity market and wider GLP-1 space has remained largely unshakeable in recent months, a crack in the company’s armor may be forming, according to at least one analyst.

A couple of decades ago, GLP-1 drugs were a specialised treatment for type-2 diabetes but, fast-forward to today, and they have become much more widespread, being sold to help people with obesity and ...

The US Food and Drug Administration on Wednesday approved a new obesity pill called Foundayo. Taken once daily, the pill is made by pharmaceutical company Eli Lilly, which also manufactures the ...

Add Yahoo as a preferred source to see more of our stories on Google. April 9 (UPI) --Eli Lilly announced that its GLP-1 weight-loss pill is available for purchase in the United States starting ...